Alzheimer's & Parkinson's Blog

Parkinson’s Disease is a movement disorder, which affects each person differently.

Join the Fight
For Brain Health

Join the Fight
For Brain Health

Frequent Misdiagnosis

One in 4 Parkinson’s cases is misdiagnosed initially. Why is diagnosing Parkinson’s such a daunting challenge? 

Consider this simple fact: the early signs of Parkinson’s (tremor, stiffness, balance disorders, constipation) overlap substantially with signs of normal aging and other neurological diseases.

The overwhelming misdiagnosis of Parkinson’s is why biomarker-testing is the next critical milestone to empowers doctors with accurate Parkinson’s diagnosis.


Patients with early and intermediate-stage Parkinson’s Disease respond initially to drugs that increase dopamine’s brain concentrations. These include:

  • Levodopa, and
  • Carbidopa

However, long-term treatment with these drugs leads to undesired severe side effects, and the benefits may decrease over time.

More recently, implantation of electrodes deep within the brain and stimulation with electrical pulses may improve voluntary movement in a subset of patients.

There is currently no treatment that slows or stops the progression of Parkinson’s. However, scientists and researchers such as Team Amprion are working hard to accelerate drug development to prevent Parkinson’s.